ILM-01

N/A

Report date: 2025/07/21 17:15:40

Base Information

Drug NameILM-01
Drug Alias NameILM-01αAβ-Gas6GAIA-Aβ
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIllimis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIllimis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A